Combination treatment for dementia or cognitive deficits...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/5377 (2006.01) A61K 31/395 (2006.01) A61K 31/41 (2006.01) A61K 31/435 (2006.01) A61K 31/445 (2006.01) A61K 31/4525 (2006.01) A61K 31/4535 (2006.01) A61K 31/454 (2006.01) A61K 31/4545 (2006.01) A61K 31/4745 (2006.01) A61K 31/495 (2006.01) A61K 31/496 (2006.01) A61K 31/4985 (2006.01) A61K 31/505 (2006.01) A61K 31/517 (2006.01) A61K 31/535 (2006.01) A61K 31/5375 (2006.01) A61K 45/06 (2006.01) A61P 25/00 (2006.01) A61P 25/14 (2006.01) A61P 25/16 (2006.01) A61P 25/28 (2006.01) A61P 25/30 (2006.01) A61P 2

Patent

CA 2359877

The present invention relates to a method of treating dementia or cognitive deficits associated with Alzheimer's Disease or Parkinson's Disease in a mammal, including a human, by administering to the mammal a D4 dopamine; receptor in combination with an acetylcholine esterase inhibitor. It also relates to pharmaceutical compositions containing a pharmaceutically acceptable carrier, a D4 dopamine receptor and an acetylcholine esterase inhibitor.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination treatment for dementia or cognitive deficits... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination treatment for dementia or cognitive deficits..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination treatment for dementia or cognitive deficits... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1787302

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.